The European Society for Medical Oncology (ESMO) Congress 2023, which took place in Madrid, Spain, gathered internationally acclaimed experts to share and deliberate on the most recent breakthroughs in oncology. In this podcast, we listen to prominent healthcare professionals offering a summary of key moments from this year’s conference.

Today we are joined by Peter Schmid (Barts Cancer Institute, London, UK), Erika Hamilton (Sarah Cannon Research Institute, Nashville, TN), Kevin Kalinsky (Emory University Hospital, Atlanta, GA), and Sherene Loi (Peter MacCallum Cancer Centre, Victoria, Australia), who share key updates in breast cancer at ESMO 2023. Topics discussed include findings from the BEGONIA (NCT03742102), KEYNOTE-522 (NCT03036488), CheckMate7FL trials (NCT04109066), novel estrogen receptor degraders vepdegestrant, as well the current state of CDK4/6 inhibitors in metastatic HER2-negative breast cancer.